Xenos Investor

Xenos is the market-leading provider of high-performance software solutions that deliver a superior Return on Information by Streamlining Enterprise Information Supply Chains. The company’s solutions, based on the scalable Xenos Enterprise Server and its components, process, extract, transform, repurpose and personalize high volumes of data and documents for storage, real-time access, ePresentment, printing and delivery in numerous formats across multiple channels.
The value of information to an organization is a function of its accessibility and reusability relative to the cost of acquiring and maintaining it. By readily repurposing, integrating with and extending the business value of existing technology infrastructure and business applications, Xenos solutions empower organizations to adapt to changing market demands. They also improve operational efficiency, enhance business processes, reduce risk for compliance management and increase employee productivity with lowered total cost of ownership both for the enterprise and for its customers.

Invests into

Industry: Regenerative Medicine
Headquarters: Richmond Hill, Ontario, Canada
Founded Date: 1979
Employees Number: 501-1000
Funding Status: M&A
Investor Type: N/A
Investment Stage: N/A
Number Of Exits: N/A

Visit Website
Register and Claim Ownership